Enjoy a flat 20% OFF on all 2025 Global Market Reports until March 31st! Use code FY25SAVE to save big—don’t miss out!
What is the current market size and future outlook for the neonatal respiratory distress syndrome treatment market?
The neonatal respiratory distress syndrome treatment market size has grown strongly in recent years. It will grow from $0.96 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing permeability and fluid accumulation within the alveoli, increasing alveolar-capillary permeability, increase in utilization of mechanical ventilation, increasing awareness among healthcare providers and parents about the importance of neonatal care, increasing healthcare investments.
The neonatal respiratory distress syndrome treatment market size is expected to see strong growth in the next few years. It will grow to $1.41 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing preference for accessories and consumables, rising NICU admissions, increasing demand for personalized medicine, increasing premature birth, increasing research and development activities. Major trends in the forecast period include automation in neonatal intensive care units (NICUs), integration of artificial intelligence (AI), technological advancement in neonatal care, surfactant therapy innovation, advanced ventilator technologies.
Get Your Free Sample of The Global Neonatal Respiratory Distress Syndrome Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp
How has the neonatal respiratory distress syndrome treatment market evolved, and what factors have shaped its growth?
The rise in incidence of premature births is expected to propel the growth of the neonatal respiratory distress syndrome treatment market going forward. Premature birth, or preterm birth, happens when a baby is born before 37 weeks of pregnancy, with those born before 32 weeks facing the most severe health risks, as a typical pregnancy lasts about 40 weeks. Premature births are increasing due to factors such as older maternal age, multiple pregnancies, health conditions, lifestyle choices, use of fertility treatments, infections, and environmental factors. Neonatal respiratory distress syndrome (NRDS) is commonly required for premature infants due to their underdeveloped lungs and insufficient production of surfactant. This treatment helps improve lung function, stabilize breathing, and reduce the risk of respiratory failure in premature babies. For instance, in December 2022, according to Tommy’s, a UK-based charity organization, the percentage of premature live births in England and Wales reached 7.9% in 2022, up from 7.5% in 2021. This marks the second consecutive year of an increase in premature births. Over 53,000 babies were born prematurely in 2022. Therefore, the rise in incidence of premature births is driving the neonatal respiratory distress syndrome treatment market.
What are the major segments of the neonatal respiratory distress syndrome treatment market?
The neonatal respiratory distress syndrome treatment market covered in this report is segmented –
1) By Therapy: Oxygen Therapy, Surfactant Therapy
2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration
3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies
Subsegments:
1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy
2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy
Order your report now for swift delivery
Which companies dominate the neonatal respiratory distress syndrome treatment market?
Major companies operating in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH
How will emerging trends drive the neonatal respiratory distress syndrome treatment market throughout the forecast period?
Major companies operating in the neonatal respiratory distress syndrome treatment market are concentrating on developing advanced technologies, such as nitric oxide generators, to enhance oxygenation, minimize respiratory complications, and offer non-invasive treatments for neonates with hypoxic respiratory failure. A nitric oxide generator is a medical device that generates and administers nitric oxide gas, commonly used to treat respiratory issues by improving oxygenation and alleviating pulmonary hypertension, particularly in neonates and critically ill patients. For instance, in June 2022, Beyond Air Inc., a US-based medical device and biopharmaceutical company, received FDA approval for LungFit PH. This innovative nitric oxide generator is designed to treat term and near-term neonates with hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). Using Beyond Air’s patented Ionizer technology, the device generates nitric oxide on demand from ambient air, providing an unlimited supply without concerns about dose or flow, and utilizes a low-power compressor to ionize nitrogen and oxygen, minimizing nitrogen dioxide (NO2) production, which is then safely filtered out via a smart filter.
What are the key regional dynamics of the neonatal respiratory distress syndrome treatment market, and which region leads in market share?
North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Neonatal Respiratory Distress Syndrome Treatment Market Report 2025 Offer?
The neonatal respiratory distress syndrome treatment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Neonatal respiratory distress syndrome treatment refers to the management of premature infants with insufficient surfactant production, leading to breathing difficulties. It involves administering exogenous surfactant therapy, providing respiratory support with mechanical ventilation or continuous positive airway pressure (CPAP), and oxygen supplementation.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20899
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
